Annika Nelde

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 641 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler et al. · Nature · 2021 · 275 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich, Annika Nelde, Jonas S. Heitmann et al. · Science Translational Medicine · 2021 · 173 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

Simon Walz, Juliane S. Stickel, Daniel J. Kowalewski et al. · Blood · 2015 · 108 citations · Full text

Life Sciences, Immunology, Oncology +17

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Anna Reustle, Moreno Di Marco, Carolin Meyerhoff et al. · Genome Medicine · 2020 · 105 citations · Full text

Medicine, Immunology, Oncology +17